No Detail Found!

Insilico Screening of Bioactive Phytochemicals against Spike Protein of COVID-19

Author(s)
Muhammad Hamza Tariq Atta-ur-Rehman School of Applied Biosciences, National University of Science and Technology, Islamabad, Pakistan
Mahjabeen Akram Paediatrics Medicine Unit 1, Services Hospital, Lahore 54000, Pakistan
Yasir Sharif Institute of Biochemistry and Biotechnology, University of the Punjab, Lahore-54590, Pakistan
Abstract
Coronavirus disease 2019 (COVID-19) is a pandemic and this disease has infected millions of people globally now. COVID-19 is caused by a novel beta coronavirus strain known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Once SARS-CoV-2 manages to enter the body, it identifies and binds to the angiotensin converting enzyme 2 (ACE2) receptors through the binding receptor of Spike Protein (S-protein). The present study aimed to investigate the phytochemicals as potential inhibitors of the binding domain of S protein so that the binding of COVID-19 with ACE2 receptors could be restrained. For this purpose, the library of 2113 phytochemicals was docked against the binding domain of the S-protein. Top ten compounds with maximum binding affinity to the active sites of target protein were further screened for ADMET properties by adopting SwissADME and ADMETsar online servers. The compounds namely Morin, Curcumin, Apigenin, Cedronolactone A and Matairesinol showed acceptable drug-like properties therefore these compounds can be proposed as effective inhibitors, disrupting the S-protein- ACE2 interaction. This study might help in the development of a natural and cost-effective drug against COVID-19. Further, in vivo and in vitro examinations are required to validate our results.
Publication Details
Page(s) 433-438
Published Journal: Pakistan Journal of Zoology, Volume: 54, Issue: 1, Year: 2022

Request the full text from PASTIC

Keywords
COVID-19, Phytochemicals, molecular docking, spike protein, Druglikeness
0

Citations

0

Downloads

114

Views